
Glenmark Pharmaceuticals Inc., USA To Launch 8.4% Sodium Bicarbonate Injection USP In November 2025
New Delhi: Glenmark Pharmaceuticals Inc., USA has announced the upcoming launch of its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL)…














